Tracking the evolution of untreated high‐intermediate/high‐risk diffuse large B‐cell lymphoma by circulating tumour DNA-Reference-Cited by-同舟云学术

Tracking the evolution of untreated high‐intermediate/high‐risk diffuse large B‐cell lymphoma by circulating tumour DNA

Published:2021-10-19 Issue:3 Volume:196 Page:617-628
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhang Sicong¹^ORCID,Zhang Tingting¹^ORCID,Liu Hengqi¹,Zhao Jing¹,Zhou Haifei²,Su Xiaoxing²,Liu Xianming¹,Li Lanfang¹,Qiu Lihua¹,Qian Zhengzi¹,Zhou Shiyong¹,Gong Wenchen³,Meng Bin³,Ren Xiubao⁴,He Jin¹,Wang Xianhuo¹^ORCID,Zhang Huilai¹

Affiliation:

1. Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center of Cancer Key Laboratory of Cancer Prevention and Therapy Sino‐US Center for Lymphoma and Leukemia Research TianjinChina

2. Berry Oncology Corp. BeijingChina

3. Department of Pathology Tianjin Medical University Cancer Institute and Hospital TianjinChina

4. Department of Immunology/Biotherapy Tianjin Medical University Cancer Institute and Hospital Tianjin China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17894